Characterization of protective anti-Fab autoantibodies in kidney graft recipients
Süsal, C.; Groth, J.; Tanzi-Fetta, R.F.; Kirste, G.; Doerr, C.; Terness, P.; May, G.; Staehler, G.; Opelz, G.
Transplantation Proceedings 24(6): 2523-2526
1992
ISSN/ISBN: 0041-1345 PMID: 1465853 Document Number: 394099
Document emailed within 1 workday
Related Documents
Valderrábano, F.; Anaya, F.; Robles, N.R.; Jofré, R. 1988: Sequential therapy with anti-thymocyte globulin and cyclosporine a in oligoanuric high-risk cadaveric kidney graft recipients Transplantation Proceedings 20(5 Suppl 6: 75-78Yagisawa, T. 1988: Clinical and pathological studies of cyclosporin-treated kidney transplant recipients. First report: Study of recipients with long-term graft function Nihon Jinzo Gakkai Shi 30(7): 865-873
Vanrenterghem, Y.; Waer, M.; De Keyser, P.; Roels, L.; Michielsen, P. 1988: Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine-associated nephrotoxicity in renal graft recipients Transplantation Proceedings 20(3 Suppl 3: 615-617
Mytilineos, J.; Scherer, S.; Trejaut, J.; Dunckley, H.; Chapman, J.; Fischer, G.; Fae, I.; Middleton, D.; Savage, D.; Bignon, J.D. 1992: Analysis of discrepancies between serologic and DNA-RFLP typing for HLA-DR in kidney graft recipients Transplantation Proceedings 24(6): 2478-2479
Kuster, J.; Binswanger, U.; von Felten, A. 1976: Non-HL-A specific anti-thrombocyte autoantibodies in patients after kidney transplantation Schweizerische Medizinische Wochenschrift 106(40): 1376
Opelz, G.; Schwarz, V.; Engelmann, A.; Back, D.; Wilk, M.; Keppel, E. 1991: Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients Transplantation Proceedings 23(1 Part 1): 373-375
Barrero Candau, R.; Morcillo Azcárate, J.; Fernández Hurtado, M.; García Merino, F.; de Agustín Asensio, J.C. 2010: Results of living donor kidney transplant in pediatric recipients, with graft obtained by laparoscopy Cirugia Pediatrica: Organo Oficial de la Sociedad Espanola de Cirugia Pediatrica 23(3): 141-143
Chan, L.S.; Traczyk, T.; Taylor, T.B.; Eramo, L.R.; Woodley, D.T.; Zone, J.J. 1995: Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies Archives of Dermatology 131(12): 1432-1437
Ignjatović, L.; Hrvacević, R.; Jovanović, D.; Kovacević, Z.; Vavić, N.; Rabrenović, V.; Tomić, A.; Aleksić, P.; Drasković-Pavlović, B.; Dujić, A.; Karan, Z.; Maksić, D. 2013: Conversion from calcineurin inhibitors to sirolimus of recipients with chronic kidney graft disease grade III for a period 2003-2011 Vojnosanitetski pregled 70(9): 848-853
Busnach, G.; Stragliotto, E.; Minetti, E.; Perego, A.; Brando, B.; Broggi, M.L.; Civati, G. 1998: Effect of n-3 polyunsaturated fatty acids on cyclosporine pharmacokinetics in kidney graft recipients: a randomized placebo-controlled study Journal of Nephrology 11(2): 87-93
Frei, U.; Margreiter, R.; Harms, A.; Bösmüller, C.; Neumann, K.H.; Viebahn, R.; Gubernatis, G.; Wonigeit, K.; Pichlmayr, R. 1987: Preoperative graft reperfusion with a calcium antagonist improves initial function: preliminary results of a prospective randomized trial in 110 kidney recipients Transplantation Proceedings 19(5): 3539-3541
Durlik, M.; Gaciong, Z.; Soluch, L.; Rowińska, D.; Kozłowska-Boszko, B.; Rowiński, W.; Szmidt, J.; Lao, M. 1996: Results of kidney transplantation in HBsAG and anti-HCV seropositive renal allograft recipients Transplantation Proceedings 28(6): 3459-3460
Kabat-Koperska, J.; Kędzierska, K.; Gołembiewska, E.; Marchelek-Myśliwiec, M.łg.; Dutkiewicz, G.ży.; Ciechanowski, K. 2012: Three clinical cases of nonrespiratory acidosis in kidney transplant recipients receiving anti-CMV therapy Annals of Transplantation 17(2): 135-140
Breimer, M.E.; Brynger, H.; Le Pendu, J.; Oriol, R.; Rydberg, L.; Samuelsson, B.E.; Vinas, J. 1987: Blood group ABO-incompatible kidney transplantation biochemical and immunochemical studies of blood group a glycolipid antigens in human kidney and characterization of the antibody response (antigen specificity and antibody class) in O recipients receiving A2 grafts Transplantation Proceedings 19(1 Part 1): 226-230
Contreras, J.L.; Eckhoff, D.E.; Cartner, S.; Frenette, L.; Thomas, F.T.; Robbin, M.L.; Neville, D.M.; Thomas, J.M. 1999: Tolerability and side effects of anti-CD3-immunotoxin in preclinical testing in kidney and pancreatic islet transplant recipients Transplantation 68(2): 215-219
Alfonso, J.; Gralla, J.; Klem, P.; Chan, L.; Wiseman, A.C.; Cooper, J.E. 2014: High-Dose Intravenous Immunoglobulin Therapy for Donor Specific Antibodies in Kidney Transplant Recipients with Acute and Chronic Graft Dysfunction: Updates on Previously Reported Cohorts Clinical Transplants 2014: 161-170
Liem, L.M.; van Noort, J.T.; Goulmy, E. 1996: Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin a Bone Marrow Transplantation 18(1): 73-78
Wang, M.; Qu, X.; Stepkowski, S.M.; Chou, T.C.; Kahan, B.D. 1996: Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus Transplantation 61(3): 458-464
Kumagai, T.; Kameko, M.; Kanai, M.; Maruyama, K. 1985: A study on autoantibodies including anti-nDNA, anti-RNP and anti-Sm antibody in various autoimmune diseases Rinsho Byori. Japanese Journal of Clinical Pathology 33(3): 293-297
Tanaka, M. 2005: RA-related autoantibodies (anti-calpastatin, anti-gp130-RAPS, and anti-FRP antibodies) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 7): 449-452